Trial intelligence / Profile preview

Dextroamphetamine for Motor Recovery After Stroke

NCT00001783Phase 2Completed

Sponsor
National Institute of Neurological Disorders and Stroke
Start
Apr 1998
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dextroamphetamine in ischemic stroke, sponsored by National Institute of Neurological Disorders and Stroke. Started Apr 1998; status: completed.

02

Drugs

dextroamphetamine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT00001783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00001783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call